These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 919451)

  • 1. [Experience with the use of lyobile and cyqualone in peptic ulcer].
    Kolomoets MIu
    Vrach Delo; 1977 Aug; (8):65-8. PubMed ID: 919451
    [No Abstract]   [Full Text] [Related]  

  • 2. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V
    Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of xylite as a cholagogue].
    Vaĭnshteĭn SG; Maksudova DKh; Pivikova MI
    Klin Med (Mosk); 1970 Jan; 48(1):126-8. PubMed ID: 5419551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic significance of biochemical study of the bile obtained by chromatic duodenal intubation from patients with chronic noncalculous cholecystitis and peptic ulcer].
    Galkin VA; Storozhuk GI
    Ter Arkh; 1973 Dec; 45(12):116-21. PubMed ID: 4779662
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of cholinolytic preparations in the treatment of patients with peptic ulcer and chronic gastritis].
    Fishzon-Ryss IuI
    Voen Med Zh; 1965 May; 5():58-63. PubMed ID: 4380574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the functional-morphological state of the gastroduodenal system in peptic ulcer associated with cholecystitis].
    Samson EI; Chernobrovyĭ VN; Maliukh LS; Gaĭdichuk SF; Kalugin VA
    Ter Arkh; 1978; 50(7):132-6. PubMed ID: 715712
    [No Abstract]   [Full Text] [Related]  

  • 8. [The chologenic and choleretic action of sorbitol].
    Grancharov V
    Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function in peptic ulcer associated with chronic cholecystitis].
    Kalugin VA; Marega IN
    Vrach Delo; 1978 Mar; (3):86-9. PubMed ID: 645047
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effectiveness of stachyren in the treatment of patients with chronic cholecystocholangitis].
    Trusov VV; Varfolomeeva TB; Oreshkov TM; Plastinina RA; Sabsaĭ LG
    Vrach Delo; 1972 Nov; 11():66-9. PubMed ID: 4659743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stomach resection and concurrent of the gallbladder and bile ducts].
    Kapral W
    Chirurg; 1968 Apr; 39(4):184-7. PubMed ID: 5687671
    [No Abstract]   [Full Text] [Related]  

  • 12. [The detection of cholecystopathies in peptic ulcer patients].
    Dikhtenko GI
    Vrach Delo; 1971 Dec; 12():40-3. PubMed ID: 5137864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and drug correction of functional disorders of bile excretion in chronic acalculous cholecystitis].
    Semendiaeva ME; Kamaeva NG; Dubrov EIa; Mal'tsev VA; Stetiukhin EM
    Sov Med; 1985; (6):12-6. PubMed ID: 4059961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative evaluation of the therapeutic effect of pequocrin and allochol in chronic cholecystocholangitis].
    Tsimmerman IaS; Mezheborskiĭ AM
    Vrach Delo; 1976; (5):77-82. PubMed ID: 969428
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic use of xylith in chronic cholecystitis].
    Kulikova ZS
    Vrach Delo; 1968 Aug; 8():23-5. PubMed ID: 5741738
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H
    Wien Med Wochenschr; 1972 Apr; 122(14):187-90. PubMed ID: 5014036
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgery for combined diseases of the stomach, duodenum and biliary tracts].
    Sveshnikov AI; Vinogradova OI
    Khirurgiia (Mosk); 1972 Oct; 48(10):16-21. PubMed ID: 4658056
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative and qualitative changes in the level of bile acids in the bile of patients with chronic hepatocholecystitis under the effect of therapy].
    Karbach IaI; Zvershkhanovskiĭ FA
    Ter Arkh; 1970 Dec; 42(12):62-4. PubMed ID: 5511307
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies].
    Hunold W
    Z Allgemeinmed; 1975 Feb; 51(5):237-41. PubMed ID: 1093341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.